Page last updated: 2024-12-06

2-aminobenzonitrile

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2-Aminobenzonitrile, also known as 2-cyanophenylamine, is a key intermediate in the synthesis of various pharmaceuticals, agrochemicals, and dyes. It's typically synthesized through the nitration of toluene followed by reduction and cyanation. Its versatile structure allows for modifications leading to diverse derivatives with various applications. Research studies focus on its potential in medicinal chemistry, particularly as a building block for anti-cancer agents and inhibitors of specific enzymes. The compound exhibits fluorescence properties and is investigated for its potential applications in organic light-emitting diodes (OLEDs) and other optoelectronic devices. '

o-aminobenzonitrile: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID72913
CHEMBL ID3561681
SCHEMBL ID71324
MeSH IDM000605722

Synonyms (49)

Synonym
aminobenzonitrile
einecs 217-549-9
brn 0907187
o-aminobenzonitrile
2-cyanoaniline
o-cyanoaniline
2-amino-benzonitrile
1885-29-6
2-aminobenzonitrile ,
anthranilonitrile
inchi=1/c7h6n2/c8-5-6-3-1-2-4-7(6)9/h1-4h,9h
benzonitrile, 2-amino-
2-aminobenzonitrile, 98%
A0861
STK802207
AKOS000120456
unii-5rxh2b211r
4-14-00-01013 (beilstein handbook reference)
5rxh2b211r ,
FT-0611231
2-cyano-1-aminobenzene
AM20060057
2-aminobenzenecarbonitrile
BP-21336
SCHEMBL71324
2-amino benzonitrile
2-aminobenzo nitrile
2- aminobenzenecarbonitrile
2-amino-1-cyano-benzene
tox21_304036
dtxsid9051824 ,
cas-1885-29-6
NCGC00357243-01
dtxcid4030380
W-107755
benzonitrile, amino-
AN-584/40186357
benzonitrile, o-amino-
CHEMBL3561681
mfcd00007631
F0020-1996
D70483
AS-10868
2-cyanoaniline;o-aminobenzonitrile
BCP33252
CS-W013598
Q27262788
EN300-20429
Z104478174
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (2)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency2.16900.003041.611522,387.1992AID1159552
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency7.07960.001530.607315,848.9004AID1224841; AID1224848; AID1224849; AID1259401
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's3 (60.00)24.3611
2020's1 (20.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 34.60

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index34.60 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.99 (4.65)
Search Engine Demand Index40.31 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (34.60)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]